welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- login
Researchers Overcome Hurdle in CRISPR Gene Editing for Muscular Dystrophy
The gene editing technique known as CRISPR is a revolutionary approach to treating inherited diseases. However, the tool has yet to be used to effectively treat long-term, chronic conditions. A research team led by Dongsheng Duan, PhD, at the University of Missouri School of Medicine has identified and overcome a barrier in CRISPR gene editing that may lay the foundation for sustained treatments using the technique.
CRISPR gene editing is inspired by the body’s natural defensive ability to fend off viruses. The technology enables researchers to alter DNA sequences by cutting out and replacing a mutation in the genome, which has the potential to treat a variety of genetic diseases and conditions. Duan, along with his collaborators at MU, the National Center for Advancing Translational Sciences at the National Institutes of Health and Duke University, are studying how to harness CRISPR to treat Duchenne muscular dystrophy (DMD).
rareRelated
-
RotM: Interview with Prof. Steve WinderFor our recent Researcher of the Month, ...
-
FDA and NIH to loosen oversight of gene therapy developmentCiting the need to safely expedite the d...
-
Why my patient advocacy organization is investing in CRISPRIn last year’s action film “Rampage,...
-
New CRISPR Method Takes on Duchenne Muscular DystrophyThe advance of CRISPR gene editing techn...
-
UCLA research could be first step toward healing the hearts of children with DuchenneAfter a progressive weakening of the mus...
-
Sarepta Announces Clinical Hold Lifted for its Duchenne Muscular Dystrophy Micro-dystrophin Gene Therapy ProgramSarepta Therapeutics, Inc., a commercial...
-
Clinical Intramuscular Gene Transfer Trial of rAAVrh74.MCK.Micro-Dystrophin to Patients With Duchenne Muscular Dystr...The proposed phase I clinical trial is a...